COVID 19 and febrile neutropenia: Case report and systematic review.

ABSTRACT:

Objectives

In pandemic conditions, patients with febrile neutropenia are also at risk of COVID-19. Aim of this systematic review is to evaluate COVID-19 cases presented with febrile neutropenia and provide information regarding incidence, clinical course and prognosis.

Methods

We systematically searched on COVID-19 and febrile neutropenia cases in PubMed, SCOPUS and Web of Science.

Results

A total of 19 febrile neutropenic patients were analyzed. A male predominance was noted. Eleven cases had hematological malignancies. Fourteen of the cases were previously received chemotherapy. Five patients had severe neutropenia: 3 had hematologic cancer and none died. 17 (89.5%) cases have pulmonary involvement and seven of them had severe disease with acute respiratory distress

SUBMITTER: Kaya T 

PROVIDER: S-EPMC8901240 | biostudies-literature | 2022 May-Jun

REPOSITORIES: biostudies-literature